GOLM1 and liver disorder: Although accumulating studies have suggested that serum GP73 might be a reliable and accurate biomarker for staging liver fibrosis and cirrhosis in CLD patients with different etiologies [11,12], the molecular mechanism relevant to the aberrant elevation of serum GP73 in liver diseases remains largely unknown.